A Ligand for CD5 Is CD5

被引:51
|
作者
Brown, Marion H. [1 ]
Lacey, Erica [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
来源
JOURNAL OF IMMUNOLOGY | 2010年 / 185卷 / 10期
基金
英国医学研究理事会;
关键词
CYSTEINE-RICH DOMAIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL SURFACE-IMMUNOGLOBULIN; POTENTIAL SELECTING LIGAND; RAT T-LYMPHOCYTES; SCAVENGER RECEPTOR; SRCR DOMAIN; MONOCLONAL-ANTIBODY; NATURAL-KILLER; B-CELLS;
D O I
10.4049/jimmunol.0903823
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recognition by scavenger receptor cysteine-rich domains on membrane proteins regulates innate and adaptive immune responses. Two receptors expressed primarily on T cells, CD5 and CD6, are linked genetically and are structurally similar, both containing three scavenger receptor cysteine-rich domains in their extracellular regions. A specific cell surface interaction for CD5 has been difficult to define at the molecular level because of the susceptibility of CD5 protein to denaturation. By using soluble CD5 purified at neutral pH to preserve biological activity, we show that CD5 mediates species-specific homophilic interactions. CD5 domain 1 only is involved in the interaction. CD5 mAbs that have functional effects in humans, rats, and mice block homophilic binding. Ag-specific responses by mouse T cells in vitro were increased when engagement of human CD5 domain 1 was inhibited by mutation or by IgG or Fab fragment from a CD5 mAb. This showed that homophilic binding results in productive engagement. Enhancement of polyclonal immune responses of rat lymph node cells by a Fab fragment from a CD5 mAb shown to block homophilic interactions provided evidence that the extracellular region of CD5 regulates inhibition in normal cells. These biochemical and in vitro functional assays provide evidence that the extracellular region of CD5 regulates immunity through species-specific homophilic interactions. The Journal of Immunology, 2010, 185: 6068-6074.
引用
收藏
页码:6068 / 6074
页数:7
相关论文
共 50 条
  • [1] Identification of a ligand for bovine CD5
    Haas, KM
    Estes, DM
    FASEB JOURNAL, 2000, 14 (06): : A965 - A965
  • [2] The identification and characterization of a ligand for bovine CD5
    Haas, KM
    Estes, DM
    JOURNAL OF IMMUNOLOGY, 2001, 166 (05): : 3158 - 3166
  • [3] CD5 - A REVIEW
    ARBER, DA
    WEISS, LM
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 1995, 3 (01) : 1 - 22
  • [4] Blood group antibodies are made by CD5(+) and by CD5(-) B cells
    Wuttke, NJ
    MacArdle, PJ
    Zola, H
    IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (05): : 478 - 483
  • [5] REACTIVITY OF THE WORKSHOP CD5 PANEL ANTIBODIES WITH THE PURIFIED CD5 ANTIGEN
    LETESSON, JJ
    LAMBOT, M
    MULUMBA, M
    DEPELCHIN, A
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 27 (1-3) : 241 - 241
  • [6] A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5
    Bikah, G
    Lynd, FM
    Aruffo, AA
    Ledbetter, JA
    Bondada, S
    INTERNATIONAL IMMUNOLOGY, 1998, 10 (08) : 1185 - 1196
  • [7] SEQUENCE OF BOVINE CD5
    YU, Q
    REICHERT, M
    BROUSSEAU, T
    CLEUTER, Y
    BURNY, A
    KETTMANN, R
    NUCLEIC ACIDS RESEARCH, 1990, 18 (17) : 5296 - 5296
  • [8] CD5 TRANSGENIC MICE
    CHEN, X
    KEARNEY, JF
    FASEB JOURNAL, 1994, 8 (04): : A470 - A470
  • [9] The multiple faces of CD5
    Burgueno-Bucio, Erica
    Mier-Aguilar, Carlos A.
    Soldevila, Gloria
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 105 (05) : 891 - 904
  • [10] Lupus and the CD5 switch
    不详
    JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (03): : 457 - 457